Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs MedX Health Corp. (MDXHF)

Insight Molecular Diagnostics Inc. and MedX Health Corp. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. and MedX Health Corp. are of similar size ($103.2M and $100.1M). MedX Health Corp. grew revenue faster over the last twelve months: 20.1% against −60.8%. MedX Health Corp. has the higher net margin (−1,087.8% vs −2,955.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Insight Molecular Diagnostics Inc. leads on 8 and MedX Health Corp. on 8.

Valuation

Metric IMDX MDXHF Diagnostics & Research median
P/E n/m n/m 35.56
P/S 66.24 23.85 4.37
P/B n/m n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 55.72 29.40 5.51
Earnings yield (49.50%) (46.67%) (1.89%)
Free cash flow yield (28.02%) (52.97%) (0.15%)

Profitability

Metric IMDX MDXHF Diagnostics & Research median
Gross margin 48.32% (1.89%) 50.89%
Operating margin (3,011.86%) (753.38%) (8.57%)
Net margin (2,955.63%) (1,087.83%) (6.37%)
Free cash flow margin (1,856.23%) (655.93%) 0.00%
Return on equity 488.68% 63.71% (2.92%)
Return on assets (123.46%) (840.71%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMDX MDXHF Diagnostics & Research median
Revenue growth (TTM) (60.77%) 20.12% 7.69%
EPS growth (last fiscal year) 64.59% (52.00%) 25.92%
Revenue growth, 5-year CAGR 27.24% (55.05%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX MDXHF Diagnostics & Research median
Debt to equity (0.04) (0.30) 0.11
Current ratio 2.00 0.02 2.02
Net debt to EBITDA (0.67) (0.40) 0.70

Dividend

Metric IMDX MDXHF Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IMDX MDXHF Diagnostics & Research median
Market cap 100.14m 103.16m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack